Brief: Mereo BioPharma Q2 Operating Income USD -7.03 Million
11/08/2026 13:16
BRIEF-Mereo BioPharma Q2 Operating Income USD -7.03 Million Aug 11 (Reuters) - Mereo BioPharma Q2 pretax profit USD -7.005 million.
- Q2 net income USD -7.005 million
Recent news on Mereo BioPharma
See all newsBrief: Sentynl Therapeutics And Mereo Biopharma Announce Option And License Agreement For Alvelestat In Alpha-1 Antitrypsin Deficiency-Associated Lung Disease
UK's Mereo BioPharma Q2 loss narrows on lower R&D spending
Brief: Mereo BioPharma Q2 Operating Income USD -7.03 Million
Brief: Mereo BioPharma Q1 Net Income USD -6.719 Million
Brief: Mereo BioPharma FY Revenue USD 500 Thousand Vs. IBES Estimate USD 520 Thousand